title: Natural killer cells and Helicobacter pylori infection: bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production.
abstract: Helicobacter pylori is known to induce a local immune response, which is characterized by activation of lymphocytes and the production of IFN-gamma in the stomach mucosa. Since not only T cells, but also natural killer (NK) cells, are potent producers of gamma interferon (IFN-gamma), we investigated whether NK cells play a role in the immune response to H. pylori infection. Our results showed that NK cells were present in both the gastric and duodenal mucosae but that H. pylori infection did not affect the infiltration of NK cells into the gastrointestinal area. Furthermore, we could show that NK cells could be activated directly by H. pylori antigens, as H. pylori bacteria, as well as lysate from H. pylori, induced the secretion of IFN-gamma by NK cells. NK cells were also activated without direct contact when separated from the bacteria by an epithelial cell layer, indicating that the activation of NK cells by H. pylori can also occur in vivo, in the infected stomach mucosa. Moreover, the production of IFN-gamma by NK cells was greatly enhanced when a small amount of interleukin-12 (IL-12) was added, and this synergistic effect was associated with increased expression of the IL-12 receptor beta2. It was further evident that bacterial lysate alone was sufficient to induce the activation of cytotoxicity-related molecules. In conclusion, we demonstrated that NK cells are present in the gastroduodenal mucosa of humans and that NK cells produce high levels of IFN-gamma when stimulated with a combination of H. pylori antigen and IL-12. We propose that NK cells play an active role in the local immune response to H. pylori infection.
authors.affiliation: Department of Medical Microbiology and Immunology and Göteborg University Vaccine Institute (GUVAX), Göteborg University, Box 435, 40530 Göteborg, Sweden.
authors.forename: Cheol H
authors.initials: CH
authors.lastname: Yun
authors.forename: Anna
authors.initials: A
authors.lastname: Lundgren
authors.forename: Josef
authors.initials: J
authors.lastname: Azem
authors.forename: Asa
authors.initials: A
authors.lastname: Sjöling
authors.forename: Jan
authors.initials: J
authors.lastname: Holmgren
authors.forename: Ann-Mari
authors.initials: AM
authors.lastname: Svennerholm
authors.forename: B Samuel
authors.initials: BS
authors.lastname: Lundin
mesh_terms: D000328:Adult; D000942:Antigens, Bacterial / Q000276:immunology / Q000494:pharmacology*; D004357:Drug Synergism; D005753:Gastric Mucosa / Q000166:cytology / Q000276:immunology; D016481:Helicobacter Infections / Q000276:immunology* / Q000382:microbiology; D016480:Helicobacter pylori / Q000276:immunology* / Q000472:pathogenicity; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis*; D018664:Interleukin-12 / Q000276:immunology / Q000494:pharmacology*; D007413:Intestinal Mucosa / Q000166:cytology / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation; D008875:Middle Aged
chemical_list: D000942:Antigens, Bacterial; D018664:Interleukin-12; D007371:Interferon-gamma
references.citation: J Immunol. 2002 Oct 15;169(8):4450-9
references.pmid: 12370380
references.citation: J Gen Virol. 2003 Aug;84(Pt 8):1961-1972
references.pmid: 12867626
references.citation: J Immunol. 2000 Nov 1;165(9):4985-93
references.pmid: 11046026
references.citation: Cell Immunol. 1995 Oct 1;165(1):33-43
references.pmid: 7671323
references.citation: Clin Exp Immunol. 1999 Aug;117(2):316-23
references.pmid: 10444264
references.citation: Blood. 2003 Jul 1;102(1):207-14
references.pmid: 12637316
references.citation: Infect Immun. 2002 Jun;70(6):3295-9
references.pmid: 12011029
references.citation: J Infect Dis. 2003 Apr 15;187(8):1165-77
references.pmid: 12695995
references.citation: FEMS Immunol Med Microbiol. 2003 May 25;36(3):159-68
references.pmid: 12738386
references.citation: J Immunol. 1998 Jul 15;161(2):755-66
references.pmid: 9670952
references.citation: J Infect Dis. 1999 Jun;179(6):1523-30
references.pmid: 10228075
references.citation: J Immunol. 2000 Oct 15;165(8):4312-8
references.pmid: 11035066
references.citation: J Immunol. 2002 May 1;168(9):4531-7
references.pmid: 11970999
references.citation: Nat Immunol. 2001 Apr;2(4):293-9
references.pmid: 11276199
references.citation: J Biol Chem. 2003 Aug 29;278(35):32552-60
references.pmid: 12807870
references.citation: J Immunol. 2000 Jan 1;164(1):64-71
references.pmid: 10604994
references.citation: Annu Rev Microbiol. 2000;54:615-40
references.pmid: 11018139
references.citation: J Clin Pathol. 1999 Sep;52(9):658-64
references.pmid: 10655986
references.citation: Curr Opin Immunol. 2002 Oct;14(5):615-21
references.pmid: 12183162
references.citation: Nat Rev Immunol. 2001 Oct;1(1):41-9
references.pmid: 11905813
references.citation: Nat Immunol. 2002 Dec;3(12):1150-5
references.pmid: 12426564
references.citation: Blood. 1996 Sep 15;88(6):2279-87
references.pmid: 8822949
references.citation: Infect Immun. 2002 Oct;70(10):5622-7
references.pmid: 12228290
references.citation: Curr Opin Immunol. 2001 Apr;13(2):154-62
references.pmid: 11228407
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5640-4
references.pmid: 10318937
references.citation: J Biol Chem. 2004 Jan 2;279(1):245-50
references.pmid: 14573621
references.citation: Science. 1999 Jul 30;285(5428):727-9
references.pmid: 10426993
references.citation: Infect Immun. 1993 Jul;61(7):3012-6
references.pmid: 8514408
references.citation: Int Immunol. 1993 May;5(5):559-63
references.pmid: 7686393
references.citation: Trends Immunol. 2001 Nov;22(11):633-40
references.pmid: 11698225
references.citation: J Immunol. 2004 Jul 15;173(2):1249-57
references.pmid: 15240717
references.citation: J Gastroenterol. 2003;38(3):216-21
references.pmid: 12673443
references.citation: Infect Immun. 2002 Nov;70(11):6383-8
references.pmid: 12379718
references.citation: J Immunol. 1997 Aug 15;159(4):1658-65
references.pmid: 9257825
references.citation: Semin Oncol. 2002 Jun;29(3 Suppl 7):27-30
references.pmid: 12068385
references.citation: J Immunol. 2001 Jul 1;167(1):375-83
references.pmid: 11418673
references.citation: J Immunol. 2000 Dec 1;165(11):6221-8
references.pmid: 11086056
references.citation: J Exp Med. 2000 Dec 4;192(11):1601-10
references.pmid: 11104802
references.citation: Annu Rev Immunol. 1997;15:749-95
references.pmid: 9143706
references.citation: J Immunol. 2002 Sep 15;169(6):3232-41
references.pmid: 12218142
references.citation: Blood. 2001 May 15;97(10):3146-51
references.pmid: 11342442
references.citation: Eur J Immunol. 2001 Oct;31(10):3121-7
references.pmid: 11592089
references.citation: Scand J Gastroenterol. 1995 Nov;30(11):1058-63
references.pmid: 8578164
references.citation: Int J Cancer. 2000 Jun 15;86(6):827-34
references.pmid: 10842197
references.citation: J Immunol. 2002 Dec 15;169(12):6977-84
references.pmid: 12471132
references.citation: Eur J Immunol. 1997 Feb;27(2):354-60
references.pmid: 9045904
references.citation: Infect Immun. 1998 Nov;66(11):5543-6
references.pmid: 9784570
references.citation: Blood. 2002 Feb 15;99(4):1289-98
references.pmid: 11830478
references.citation: Eur J Immunol. 1992 Jan;22(1):23-9
references.pmid: 1370415
references.citation: Nat Rev Immunol. 2003 May;3(5):371-82
references.pmid: 12766759
references.citation: Nat Immunol. 2002 Jan;3(1):83-90
references.pmid: 11743585
references.citation: Nat Immunol. 2002 Feb;3(2):189-95
references.pmid: 11812997
references.citation: J Immunol. 2002 Nov 15;169(10):5377-81
references.pmid: 12421908
references.citation: J Immunol. 2000 Jun 1;164(11):5998-6004
references.pmid: 10820283